Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	IcoSema	646
Overall Study	STARTED	Insulin Icodec	645
Overall Study	Treated	IcoSema	644
Overall Study	Treated	Insulin Icodec	644
Overall Study	Full Analysis Set	IcoSema	646
Overall Study	Full Analysis Set	Insulin Icodec	645
Overall Study	Safety Analysis Set	IcoSema	644
Overall Study	Safety Analysis Set	Insulin Icodec	644
Overall Study	COMPLETED	IcoSema	611
Overall Study	COMPLETED	Insulin Icodec	611
Overall Study	NOT COMPLETED	IcoSema	35
Overall Study	NOT COMPLETED	Insulin Icodec	34

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05352815/flow